Influence of aspirin on inflammatory markers in patients after acute myocardial infarction

被引：49

作者：

Solheim, S ^{[1
]}

Arnesen, H

Eikvar, L

Hurlen, M

Seljeflot, I

机构：

[1] Univ Oslo, Ulleval Hosp, Dept Cardiol, Ctr Clin Res, N-0407 Oslo, Norway

[2] Univ Oslo, Ulleval Hosp, Dept Clin Chem, N-0407 Oslo, Norway

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 07期

关键词：

D O I：

10.1016/S0002-9149(03)00897-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this study was to assess the influence of aspirin on selected inflammatory markers in patients recovering from acute myocardial infarction (AMI). Patients participating in the Warfarin Aspirin Re-lnfarction Study-II were randomized to either aspirin 160 mg/day or aspirin 75 mg/day + warfarin, or warfarin alone after AMI. After AMI, aspirin 160 mg/day was associated with significantly lower levels; of high-sensitivity C-reactive protein and tumor necrois factor-alpha than warfarin alone over 4 years. However, the same levels were not predictors for clinical end points. (C) 2003 by Excerpta Medica, Inc.

引用

页码：843 / 845

页数：3

共 13 条

[1] Warfarin, aspirin, or both after myocardial infarction. [J].

Hurlen, M ;

Abdelnoor, M ;

Smith, P ;

Erikssen, J ;

Arnesen, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (13) :969-974

[2] The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction [J].

Hurlen, M ;

Seljeflot, I ;

Arnesen, H .

SCANDINAVIAN CARDIOVASCULAR JOURNAL, 1998, 32 (04) :233-237

[3] Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin [J].

Ikonomidis, I ;

Andreotti, F ;

Economou, E ;

Stefanadis, C ;

Toutouzas, P ;

Nihoyannopoulos, P .

CIRCULATION, 1999, 100 (08) :793-798

[4] INHIBITION OF NF-KAPPA-B BY SODIUM-SALICYLATE AND ASPIRIN [J].

KOPP, E ;

GHOSH, S .

SCIENCE, 1994, 265 (5174) :956-959

[5] Interleukin-10 blocks atherosclerotic events in vitro and in vivo [J].

Oslund, LJP ;

Hedrick, CC ;

Olvera, T ;

Hagenbaugh, A ;

Territo, M ;

Berliner, JA ;

Fyfe, AI .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (12) :2847-2853

[6] Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, M ;

Sacks, F ;

Lepage, S ;

Braunwald, E .

CIRCULATION, 2000, 101 (18) :2149-2153

[7] Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels [J].

Ridker, PM ;

Rifai, N ;

Pfeffer, MA ;

Sacks, FM ;

Moye, LA ;

Goldman, S ;

Flaker, GC ;

Braunwald, E .

CIRCULATION, 1998, 98 (09) :839-844

[8] Inhibition of proinflammatory cytokine production by pravastatin [J].

Rosenson, RS ;

Tangney, CC ;

Casey, LC .

LANCET, 1999, 353 (9157) :983-984

[9] Mechanisms of disease - Atherosclerosis - An inflammatory disease [J].

Ross, R .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (02) :115-126

[10] THE PATHOGENESIS OF ATHEROSCLEROSIS - A PERSPECTIVE FOR THE 1990S [J].

ROSS, R .

NATURE, 1993, 362 (6423) :801-809

← 1 2 →